Learn More
BACKGROUND This study evaluates persistence and severity of docetaxel-induced neuropathy (peripheral neuropathy (PN)) and impact on health related quality of life in survivors from early-stage breast cancer. METHODS One thousand and thirty-one patients with early-stage breast cancer, who received at least one cycle of docetaxel and provided information on(More)
  • 1